The Collaborative Market Data Network -
serving the Public interest of Transparency in Debt Capital Markets
The Collaborative Market Data Network
Serving Transparency in Capital Markets
The Collaborative
Market Data Network

GLAXOSMITHKLINE CAPITAL PLC [CRP-HLTH-PHARMA] [A+]

Post Date: 10 September 2026

Glaxosmithkline Capital Plc has priced a USD denominated multi tranche syndicated Yankee Bond.

For all the deals placed in the market today use the Bond Market or Money Market Viewers.

Issuer Details
Issuer Glaxosmithkline Capital Plc
LEI 549300U0LV41VX7LEP38
Industry Pharmaceuticals
Country United Kingdom
Issuer Description GlaxoSmithKline (GSK) Headquartered in the UK and with operations based in the US, the group is one of the leading pharmaceutical companies, with an estimated seven per cent of the world's pharmaceutical market..
Generic Credit Rating [Login to see full details]
Moody's Credit Rating [Login to see full details]
S&P Credit Rating [Login to see full details]
Fitch Credit Rating [Login to see full details]

 

Trade Details
Security Type Bond
Amount USD [Login to see full details]
Total Amount including taps USD [Login to see full details]
Total Amount Outstanding USD [Login to see full details]
Total Order Book USD [Login to see full details]
Structure Floating Rate
Reoffer [Login to see full details]
Term [Login to see full details]
Trade Date [Login to see full details]
Settlement Date [Login to see full details]
Maturity Date [Login to see full details]
Yield Notes [Login to see full details]

Login to see if this deal qualifies as a Green Bond or Social Bond or other type of ESG Bond.

A Yankee bond is an USD-denominated bond issued by a non-USA entity in the USA Foreign Bond market.

Check here for all issuer’s year to date financings.


Continue reading this article?

If you are an Issuer, Dealer (Syndicate/Origination/Trading/Sales) or a Qualified Institutional Investor, a Capital Markets Lawyer or Regulator please try full access.
Register here

Already a subscriber?

Please Sign in